Company / Shareholders' Equity
MANNKIND CORP Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$51.0M
FY2025
5-year range
-$250.5M / -$51.0M
FY2021-FY2025
Trend
+35.3%
vs FY2024
Sector context
#197 of 215
Health Care
What the data says
MANNKIND CORP reports negative total equity of -$51M in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$51M in FY2025.
Improved from -$246M to -$51M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 215This company -$51.0M Sector average $2.6B
▼
-102.0% below sector average
Key checks
Key Insights
- MANNKIND CORP's shareholders' equity has grown for 3 consecutive years.
- In FY2025, shareholders' equity increased 35.3% year-over-year.
- Ranks #197 out of 215 companies in the Health Care sector.
- Lowest shareholders' equity in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -2.74 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$51.0M | +35.3% |
| FY2024 | -$78.8M | +68.0% |
| FY2023 | -$246.2M | +1.7% |
| FY2022 | -$250.5M | -19.7% |
| FY2021 | -$209.3M | -16.0% |
| FY2020 | -$180.4M | +5.3% |
| FY2019 | -$190.5M | -8.8% |
| FY2018 | -$175.1M | +18.5% |
| FY2017 | -$214.7M | -17.0% |
| FY2016 | -$183.6M | +47.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026